Therapy Evading Cancers Suppliers & Manufacturers

Cellular Technology Limited (CTL) is a biotechnology company headquartered in Shaker Heights, a suburb of Cleveland, Ohio, with locations and distributors worldwide. We presently have around 180 full-time employees. Our company is family owned and ...

Owl Biomedical, Inc. was founded in 2011 to expand the use of its exclusive cell sorting MEMS technology for cell therapy, cancer diagnostics and basic research. Operating in Santa Barbara, California, Owl Biomedical was purchased in 2013 by ...

We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re ...

At Kura Oncology, we are committed to realizing the promise of precision medicines for the treatment of cancer. The genomics revolution is transforming how we treat cancer. We now understand that a patient’s response to treatment depends in part on ...

We believe in the patient above all – for their comfort and for their future. We are shaping the future of healthcare through innovative technologies that create life-changing experiences for patients all over the world. Our regulatory cleared ...

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond. Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, ...

Continuing To Do More To Save More Lives. Theragenics was founded in 1981 and quickly became a global leader in the manufacture of radioactive brachytherapy seeds for the treatment of localized prostate cancer. We began diversifying operations in ...

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and ...

Physiomics are a leading oncology consultancy using proprietary state of the art Virtual TumourTM technology and other tools to predict and better understand the effects of cancer treatments. We work with partners developing cancer drugs to help ...

Xstrahl is a prominent global provider specializing in the development and delivery of superficial radiation therapy devices and advanced preclinical radiation research systems. The company is actively engaged in connecting experts to further the ...

ImCare Biotech is a biotechnology company founded in 2011 by Dr. Xuanyong Lu, formerly a professor at Drexel University’s Institute for Biotechnology and Virology. The company’s primary products in development are innovative diagnostic biomarkers as ...

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...

Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing a patented product platform of novel molecules from our proprietary socially responsible pain management therapeutics to treat patients with a ...

HRGN is a clinical-stage biotechnology company that uses a patient’s own stem cells that are grown on a hollow tubular scaffold to regenerate organ tissue damaged from cancer, trauma, birth defects or other diseases. The patient’s stem ...

Virtual Incision is on a mission to miniaturize robotic surgery, so more patients, surgeons, and healthcare facilities can have access to its benefits every day. We are problem solvers focused on patients and customers as our first priority. We have ...

We are a clinical-stage biotechnology company pioneering the treatment of cancers with a technology platform that allows the direct delivery of immunotherapeutic payloads within the tumor microenvironment. Intrinsic resistance significantly reduces ...

Isotopia Molecular Imaging was established in 2007 by renowned Israeli scientists and experts in the field of radio pharmaceuticals, and in collaboration with the International Metronotario investment organization. Advancing cancer diagnosis and ...

Self-screen has a long history and track record in translational HPV related science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of HPV related cancer screening into routine practice. Our ...

ORYX’ development strategy bridges the gap between academic research and the pharmaceutical industry for new cancer therapies. Today, the company is developing three clinical cancer immunotherapy projects in indications with high unmet medical need. ...

Alpha-1 Biologics was founded by Cynthia L. Bristow, PhD, in June, 2011 for the purpose of developing patented biotechnology related to the generation of immune cells from stem cells within the body to treat immunodeficiency with the following ...